Gene · 1894
Papers1,404
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,404
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing. | Nat Commun | 2023 | 38114498 | PubTator, text mining | PubMed |
| RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling. | Sci Signal | 2023 | 38113333 | PubTator, text mining | PubMed |
| Age-associated changes in lineage composition of the enteric nervous system regulate gut health and disease. | Elife | 2023 | 38108810 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review. | Cancer Med | 2023 | 38098217 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of FXR1 across pan-cancer: Unraveling its diagnostic, prognostic, and immunological significance. | Medicine (Baltimore) | 2023 | 38050239 | PubTator, text mining | PubMed |
| Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization. | J Exp Clin Cancer Res | 2023 | 38049814 | PubTator, text mining | PubMed |
| A YTHDF-PABP interaction is required for m6 A-mediated organogenesis in plants. | EMBO Rep | 2023 | 38009565 | PubTator, text mining | PubMed |
| The Effects of Deregulated Ribosomal Biogenesis in Cancer. | Biomolecules | 2023 | 38002277 | PubTator, text mining | PubMed |
Multigene Profiling of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma Identifies Prognostic Cancer Driver Genes Associated with Epithelial-Mesenchymal-Transition Progression and Chemoresistance. | Cancers (Basel) | 2023 | 38001588 | PubTator, text mining | PubMed |
| Prognostic gene HLA-DMA associated with cell cycle and immune infiltrates in LUAD. | Clin Respir J | 2023 | 37972401 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors. | Cancer Res | 2023 | 37934103 | PubTator, text mining | PubMed |
| Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process. | Sci Rep | 2023 | 37828118 | PubTator, text mining | PubMed |
| Insights into the conservation and diversification of the molecular functions of YTHDF proteins. | PLoS Genet | 2023 | 37816028 | PubTator, text mining | PubMed |
| Retracted: miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2. | Comput Math Methods Med | 2023 | 37811240 | PubTator, text mining | PubMed |
| Identification and verification of microtubule associated genes in lung adenocarcinoma. | Sci Rep | 2023 | 37752167 | PubTator, text mining | PubMed |
| Integrated analysis of SKA1-related ceRNA network and SKA1 immunoassays in HCC: A study based on bioinformatic. | Medicine (Baltimore) | 2023 | 37746945 | PubTator, text mining | PubMed |
| Phosphotyrosine proteomics in cells synchronized at monopolar cytokinesis reveals EphA2 as functioning in cytokinesis. | Exp Cell Res | 2023 | 37726045 | PubTator, text mining | PubMed |
| Mechanosensitive accumulation of non-muscle myosin IIB during mitosis requires its translocation activity. | iScience | 2023 | 37720093 | PubTator, text mining | PubMed |
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1894/papers?page=5